Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Vesigen Therapeutics, Inc.

News headline image
Vesigen Highlights Key in vivo and Targeted Tropism Data Advancements for Non-Viral Delivery Platform at 2024 ASGCT and ARVO Annual Meetings
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen to Present New Preclinical Data on Ophthalmology Applications of Engineered ARMMs at 2024 ARVO Annual Meeting
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen to Present New Preclinical Data on Engineered ARMMs Technology at 2024 ASGCT Annual Meeting
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen to Present at the 2024 Cell and Gene Meeting on the Med
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen Receives National Institutes of Health Award in Targeted Genome Editor Delivery Challenge
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen Highlights Data Demonstrating Directed Tropism of Non-Viral Delivery Platform at the 30th Annual Congress of the European Society of Gene & Cell Therapy
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen Highlights Non-Human Primate Biodistribution of Non-Viral Technology and Functional Delivery of Genome Editors In Vivo at the Cracking the Code: The Dawn of Nucleic Acid Medicines Meeting
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen to Present at the 2023 Cell and Gene Meeting on the Mesa
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen Highlights New Data on Non-Viral Delivery Platform at the Exosome Based Therapeutic Development Summit
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen Highlights Therapeutic Platform for Non-Viral Delivery of Gene Editors and RNA at ASGCT 2023
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen Therapeutics Announces Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen Therapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance (FARA) to Develop a Targeted Genome Editing Therapeutic Strategy
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen Therapeutics, Inc. Announces Expansion of Scientific Advisory Board
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen Therapeutics Names Rakhshita Dhar to Board of Directors
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen Therapeutics Appoints Paulash Mohsen as Chief Executive Officer
From Vesigen Therapeutics, Inc.
Via Business Wire
News headline image
Vesigen Therapeutics Presents at 3rd Exosome-Based Therapeutic Development Summit: Expanding the Therapeutic Boundaries of Exosomes
From Vesigen Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.